Is anyone participating in a clinical trial for pancreatic cancer?

Posted by lfitz @lfitz, Sep 25, 2022

Is anyone participating in a clinical trial for pancreatic cancer? My husband’s PC is not genetic. He has tried Folfirinox. He was allergic to Oxaliplatin and the Folfiri was not effective. He did Xeloda during his radiation. He did 2 months of Gemcitibine and Abraxane with severe side effects and no good days during the 2 months. It did work well though. He has grade 3/4 neuropathy. He is now stage 4 and only options appear to be no treatment and enjoy what time he has left, a decreased dose of gemcitibine and abraxane , or a clinical trial.

Interested in more discussions like this? Go to the Pancreatic Cancer Support Group.

@patti303

Ask your oncology dietician for food choice advice (correct nutrition is super important) and keep your doctor advised of "any and all symptoms and issues". You may want stock up your cupboard prior to infusion day and include some quick and easy things to eat for days you are tired or not up to snuff. Keep a note pad within reach and write everything down or use your phone notepad. This chemo clouds the brain and if you don't write it down you won't remember what to tell/ask your doctor or support group. They have all sorts of treatments for nausea, etc., but you must let them know. Don't be shy. They want this treatment to be successful and they will work with you. BTW, I was freaked out when I was told about the whole pump thing, but it was no big deal. Sending good wishes!

Jump to this post

yes,the pump thing sort of freaked me out also.but since its only 2 days every other week I thought maybe not to bad.Not happy about the brain fog .Hoping it doesn't get too bad.

REPLY
@stageivsurvivor

I had the common side effects of increasing sensitivity to cold, neuropathy in the fingers and feet from oxaliplatin, and diarrhea from the Irinotecan. I never experienced nausea of vomiting and my appetite was very good throughout the 24 months I received chemo.

The neuropathy in the fingers cleared within a year of finishing the treatment. The feet took much longer. I did not notice improvement until 2.5 years after finishing Folfirinox. From that point improvement was slow and fairly steady. it took 7.5 years to fully resolve but I had a very good quality of life despite the neuropathy and made adjustments. Gabapentin relieved any discomfort I experienced. For me, any discomfort from doing Folfirinox was well worth doing it as it contributed to being declared not only NED in 2016 but now cured of stage IV disease.

Jump to this post

So very glad that you are doing well!!

What was the reasoning for 24 months of chemo? I’ve for 14 Folfirinox treatments, HIPEC, now starting radiation. I’m stage 4 with it locally advanced in my pancreatic fluid (reason for the HIPEC)

REPLY

I found that the initial medication used at the time of the infusion, Emend and aloxi wear off towards the end of the treatment cycle so I tried taking medication about 30 hours after the start of the infusion and it seemed to help

REPLY

I often watch the Pancreatic Cancer Action Network’s seminars. I just received an email with info on one about ‘Clinical Trials’ that can be accessed onJan 26. I really like and respect this organization-and the Mayo moderator gave me permission to share this link to a seminar about Pancreatic Cancer trials. I just want to be able to help as many people as possible. I am thankful that I have not needed a clinical trial, but it may help some people who have reached the end of standard therapies. God Bless!
https://pancan.org/facing-pancreatic-cancer/patient-services/educational-events/event/webinar/ctam-2023-pancreatic-cancer-clinical-trials-what-you-need-to-know/

REPLY

I am at a crossroads and find it a somewhat difficult out decision.
I qualify for one that will require me to stop the chemo that is currently working well. Perhaps that means it’s a great time to try a possible cure.
Or perhaps I could be derailing myself .

I am healthy, active and working. I’m told the side effects have proven to be minimal. Have you faced these decisions?

REPLY
@gamaryanne

I am at a crossroads and find it a somewhat difficult out decision.
I qualify for one that will require me to stop the chemo that is currently working well. Perhaps that means it’s a great time to try a possible cure.
Or perhaps I could be derailing myself .

I am healthy, active and working. I’m told the side effects have proven to be minimal. Have you faced these decisions?

Jump to this post

I have absolutely nothing useful to offer except to say I'm interested in this decision-making process as well. I replied in part to move your thread up to the top, in hopes that others will see it and respond. Hope it works!

REPLY
@gamaryanne

I am at a crossroads and find it a somewhat difficult out decision.
I qualify for one that will require me to stop the chemo that is currently working well. Perhaps that means it’s a great time to try a possible cure.
Or perhaps I could be derailing myself .

I am healthy, active and working. I’m told the side effects have proven to be minimal. Have you faced these decisions?

Jump to this post

Most “standard of care” (SoC) treatment regimens are just that-standard. You get standard results and for pancreatic cancer, the statistics are out there on achieving long-term survival and cure.

My professional experience has been in the fields of clinical cancer, immunology and stem cell research. When I got my diagnosis in 2012, I knew right from the start that it was going to take a clinical trial to achieve something better than standard. So I started looking for a clinical trial shortly after my Whipple procedure. The trial search became more urgent when I was diagnosed with metastatic disease in the liver as the first chemo regimen failed.

Now it was a race against time as it was likely the second chemo would stop or the side effects would have a significant impact on quality of life. The things to be aware of with clinical trials- they require the participant to meet eligibility requirements based on physical assessment, blood chemistry and hematology parameters. All phase I trials are open label meaning you get the test compound. No one is assigned into a control group receiving the current SoC treatment. Phase II can be either open label, single or double blinded and may have a control group. If the trial is randomized, it is done by computer so the participant has no say in the matter. And if double blind, you nor the oncologist will be aware if you are receiving the SoC treatment or the test drug until the trial is concluded.

So things to consider are: time you have been on SoC and what is the percentage of shrinkage of tumor(s) now compared to prior scans? Are they slowing down or no change in tumor(s) meaning stable?

How often has a trial that you meet the criteria for been offered?

Is this a phase I/II trial where you will receive the drug and automatically move into phase II if phase I testing is successful?

Is it starting off as a phase II trial with or without a control group where it is a randomized trial? Regardless of whether it is randomized or not, is it single-blinded or double-blinded? If it is a new class of drug for which there is no comparison, the phase II portion will not be randomized or blinded. This was the situation I had where the trial was not blinded so I as well as my oncologist knew the drug was being administered.

Is it phase III where the trial most likely be randomized?

Earlier phase (I &II) trials have more stringent requirements on physical assessment. Phase III trials will take less healthy participants but you are then contending with a randomized trial of not knowing if you will be in the test or control arm.

If the trial doesn’t work, you may still have other SoC treatments to fall back on and they won’t have as stringent a requirement on physical assessment.

It took me more than 14 months of searching until an ideally-suited trial opened. My chemo was still working but for how much longer was anyone’s guess. It was Folfirinox and I did 24 cycles of it at full dose of the higher, first generation of it. It was alternated with 22 cycles of 5-FU/Leucovorin. I had chemo induced peripheral neuropathy as my worst side effect, with other not-so-pleasant side effects. The combination of the inordinate amount of chemo I did (well beyond standard of care) followed by the clinical trial achieved the desired goal not only of N.E.D., but cure. June will mark 12 years of an event no one thought possible when I started out on this journey. No one ever thought it possible to cure late stage disease by chemotherapy and a targeted trial. Now there is increasing reports it is possible to achieve albeit still a small number. No one knows who will become an “exceptional responder” as the NCI classifies them. A clinical trial gave me my life back and I am not only surviving, but thriving.

REPLY
@stageivsurvivor

Most “standard of care” (SoC) treatment regimens are just that-standard. You get standard results and for pancreatic cancer, the statistics are out there on achieving long-term survival and cure.

My professional experience has been in the fields of clinical cancer, immunology and stem cell research. When I got my diagnosis in 2012, I knew right from the start that it was going to take a clinical trial to achieve something better than standard. So I started looking for a clinical trial shortly after my Whipple procedure. The trial search became more urgent when I was diagnosed with metastatic disease in the liver as the first chemo regimen failed.

Now it was a race against time as it was likely the second chemo would stop or the side effects would have a significant impact on quality of life. The things to be aware of with clinical trials- they require the participant to meet eligibility requirements based on physical assessment, blood chemistry and hematology parameters. All phase I trials are open label meaning you get the test compound. No one is assigned into a control group receiving the current SoC treatment. Phase II can be either open label, single or double blinded and may have a control group. If the trial is randomized, it is done by computer so the participant has no say in the matter. And if double blind, you nor the oncologist will be aware if you are receiving the SoC treatment or the test drug until the trial is concluded.

So things to consider are: time you have been on SoC and what is the percentage of shrinkage of tumor(s) now compared to prior scans? Are they slowing down or no change in tumor(s) meaning stable?

How often has a trial that you meet the criteria for been offered?

Is this a phase I/II trial where you will receive the drug and automatically move into phase II if phase I testing is successful?

Is it starting off as a phase II trial with or without a control group where it is a randomized trial? Regardless of whether it is randomized or not, is it single-blinded or double-blinded? If it is a new class of drug for which there is no comparison, the phase II portion will not be randomized or blinded. This was the situation I had where the trial was not blinded so I as well as my oncologist knew the drug was being administered.

Is it phase III where the trial most likely be randomized?

Earlier phase (I &II) trials have more stringent requirements on physical assessment. Phase III trials will take less healthy participants but you are then contending with a randomized trial of not knowing if you will be in the test or control arm.

If the trial doesn’t work, you may still have other SoC treatments to fall back on and they won’t have as stringent a requirement on physical assessment.

It took me more than 14 months of searching until an ideally-suited trial opened. My chemo was still working but for how much longer was anyone’s guess. It was Folfirinox and I did 24 cycles of it at full dose of the higher, first generation of it. It was alternated with 22 cycles of 5-FU/Leucovorin. I had chemo induced peripheral neuropathy as my worst side effect, with other not-so-pleasant side effects. The combination of the inordinate amount of chemo I did (well beyond standard of care) followed by the clinical trial achieved the desired goal not only of N.E.D., but cure. June will mark 12 years of an event no one thought possible when I started out on this journey. No one ever thought it possible to cure late stage disease by chemotherapy and a targeted trial. Now there is increasing reports it is possible to achieve albeit still a small number. No one knows who will become an “exceptional responder” as the NCI classifies them. A clinical trial gave me my life back and I am not only surviving, but thriving.

Jump to this post

I'm not the OP, but thank you for your explanation! I have a question: What was the medication that you used during the clinical trial? Also, are you on any sort of maintenance med now? If so, what? I'm not yet ready to explore a trial, but I am poking around for additional treatment options and wondered whether the med(s) you took were now approved and available. Thanks for any info you can provide.

REPLY
Please sign in or register to post a reply.